For people with diabetes, rapid improvement in blood glucose control may occasionally be associated with transient worsening of diabetic retinopathy
The semaglutide versus tirzepatide comparison covers this head-to-head data in detail

Marek focuses on hormone optimization with lab-driven protocols and partner clinicians - Marek is generally more expensive and expects lab testing - Not a direct substitute for a weight-loss-only GLP-1 subscription - See Marek Health reviews Pomegranate Health vs LillyDirect or Novo self-pay: - LillyDirect sells Zepbound to self-pay patients at ~$350-$550/month for FDA-approved product - Novo self-pay options for Wegovy and Ozempic are more limited but expanding - Brand products have published stability, standardized manufacturing, and no compounding regulatory question - Increasingly the default for patients without insurance coverage - See where to buy tirzepatide Pomegranate Health vs a local compounding pharmacy: - Bypasses the telehealth middleman and subscription layer - Requires you to find a PCAB-accredited local compounding pharmacy that can serve you - Usually cheaper per month once the setup is complete, but requires more self-advocacy and often an in-person prescriber - Not practical for patients without a clinician willing to write the prescription The rule of thumb: for most patients, if insurance covers brand GLP-1 use the brand

Mood By mood, were referring to DSIPs potential effects on stress and anxiety
It is FDA-approved for use by Hong Kong medical professionals for reducing visceral fat in HIV-associated lipodystrophy but is also explored for its potential benefits in fat loss, muscle preservation, and cognitive function